Skip Main Navigation
Page Content

Save This Event

Event Saved

Invest In Innovation - High Yield or Hazard?

Innovation Forum Barcelona

Tuesday, 9 May 2017 from 17:00 to 21:00 (CEST)

Invest In Innovation - High Yield or Hazard?

Ticket Information

Ticket Type Sales End Price Fee Quantity
Business Angel 6 May 2017 Free €0.00
Venture Capital 6 May 2017 Free €0.00
Company 6 May 2017 €20.00 €1.80
Entrepreneur 6 May 2017 Free €0.00

Who's Going

Loading your connections...

Share Invest In Innovation - High Yield or Hazard?

Event Details

How many times did you hear about "Deep Science" and then hesitated? Maybe it is time for you to drill down. 

This event will bring Spain's leading financial institutions and profesional investors, that have no affinity to health tech, biotech and the rest of the deep science sectors. The aim is to introduce and effectively communicate why investing in science ventures may be an excellent alternative for investment.

The objectives of this event are to:
-Bring together the Spanish Business Angel Networks’ members in one exclusive event
-Bring top European investors and investment professionals from different sectors
-Enable Spanish investors to attend an exceptional networking event
-Make national investors more confident about investing in deep science
-Facilitate the growth of Spanish network of investors

*Please note, this event is exclusively for investors and start ups. 

 Agenda  (please note that program may change slightly):

17:00 Welcome and opening - Maria Chatzou, President Innovation Forum Barcelona

17:15 Introduction to science and innovation-based entrepreneurship in Catalonia
                                               - Albert Barbera, Director of Biocat

17:30 Panel Discussion: The investment challenges entrepreneurs face 
Marc Ramis - Serial Entrepreneur & CEO & Co-founder of Senolytic Therapeutics

             Panel Speakers:
             -Teresa Tarrago, CEO & Co-founder of Iproteos
Laszlo Bax, CEO & Co-founer of Braingaze
Davide D'Amico, CEO & Co-founer of ZeClinics
Markus Wilhelms, CEO & Co-founder of MowoOT
             - Alfons Nonell,
 CEO & Co-founder of Mind the Byte
18:10 KEYNOTE: Investing in Healthcare - Opportunities and risks of backing complex science focused companies in regulated sectors
             - Nick Ibery, Health & Life Sciences Specialist Investor, Senior Advisor to Innovation Forum
18:40 Panel Discussion: The role of investors in the ecosystem 
Marta Emerson, Vice-President & Co-founder of AMCES

   Panel Speakers:
Lluis Pareras, Director at HealthEquity SCR
Xavier Pont, Co-founder of Ship2B
Ignacio Fonts, Managing Partner at Inveready 
Josep Mora, Managing Director at Idodi Venture Capital
Sara Ylipoti, COO at Conector Accelerator 

19:20 KEYNOTE: What VCs are looking for in a science-based venture
           - Josep Sanfeliu, General Partner at Ysios Venture Capital
19:50 Closing remarks -  Joao Curado - Vice-President Innovation Forum Barcelona
20:15 Networking time


Confirmed keynote speakers (so far):

Risks & benefits of science and innovation-based venture investments-  Nicholas Ibery,  
Health and Life Sciences Specialist Investor, Senior Advisor to Innovation Forum Council Member and Honorary Treasurer the New Technology in Medicine Council, the Royal Society of Medicine 

Nick is a health and life sciences specialist in the UK who has held a range of leadership roles spanning across the sector. He started his career as a surgeon and has spent several years advising the Government in Whitehall. Nick was actively involved in the UK Government’s recent pro-market healthcare reforms. He has held a range of roles at the Department of Health with the Government’s the Strategy Unit and the Medical Directorate. Nick headed up the Secretariat for the National Medical Directors at the Department of Health, helping to translate best clinical evidence into workable policy and was an advisor to Sir Bruce Keogh, the NHS National Medical Director. 

As well as his roles as an investor, Nick has held a wide range of senior positions in the sector as an advisor. He is a Chairman Emeritus of the Leadership Group, Member of the Council and an Honorary Treasurer of the New Technology in Medicine Section at the Royal Society of Medicine. He has been a Senior Advisor to Novartis AG, Senior Advisor to Bupa Plc. and 3i Plc.’s Global Private Equity practice. 
Introduction to science and innovation-based entrepreneurship in Catalonia  - Albert Barberà, 
Director General - CEO at Biocat, BioRegion of Catalonia 

Mr. Barberà is currently the director of Biocat, the governmental organization that coordinates and promotes life sciences sector in Catalonia. He has a degree in Chemistry and Pharmacy and a PhD in Biochemistry and Molecular Biology. Mr. Barberà has held several positions in science management, first as the manager of the Institute of Health Carlos III Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), later as scientific coordinator at IDIBAPS and, finally, as director of the IDIBGi. Over his career, he has obtained professional experience in both research and management of knowledge and innovation in the biomedical research environment and in health.

Panel Discussion : The Investment Challenges entrepreneurs face 

Marc Ramis - Serial Entrepreneur and co-founder and CEO of Senolytic Therapeutics

Marc is really interested in translational science and bio-entrepreneurship projects. Currently, He is the co-founder and CEO of Senolytic Therapeutics, a company that develops new medicines targeting senescence cells . Also, he is co-founder of Tech & Business Innovation (TBI), an academic unit focused on knowledge exchange and corporate-academic partnerships. Marc is a strategic advisor and board member for multiple organizations and a co-founder of several companies. Currently, Marc is also implementing a Entrepreneurs-in-Residence programs at the UPV, IDIBELL and IRB Barcelona. From 2010 to 2012, Marc was working for Isis Innovations/University of Oxford as an associate consultant in Spain and LATAM. From 2007 to 2011, Marc was working at Endor, a nanomedicine company based in Spain. During this period, he was R&D director (drug-delivery nanosystems for cancer therapy) and Business Development director (launched several nanotechnology products to the cosmetic and textile markets).

·Teresa Tarragó: Iproteos
·Laszlo Bax: Braingaze
·Alfons Nonell: Mind the Byte
·Markus Wilhelms : Moowoot
Panel Discussion : The role of investors in the ecosystem

Marta Emerson
- Vice president Globat at Scaale Group 
Entrepreneur, senior manager, mentor, speaker, and passionate about helping others grow. Marta has 10 years experience on angel investment through managing and helping launch two angel networks, Keiretsu Forum Spain and Cross Border Angels.  
She started and managed business like, hello comunicación and now, 
She has been Vice President Globat at Scaale Group for 5 years, a multinational group HQ in San Francisco (California) where I have lived for 4 years. Scaale is dedicated to help companies grow through capital, international sales and talent. 
As Vice President at Scaale I have travelled over 150 days a year to India, China, Europe, Latam, USA and this allows me to have a global prespective on how to do business in different parts of the world and how to manage teams in remote. I have conducted job interviews to candidates in India, China, USA, UK and Spain. 
Over the last 10 years I have seen over 4,000 executive summaries of companies raising capital from different countries. 
I enjoy mentoring entrepreneurs and performing workshops and conferences. I have conducted over 200 conferences in 8 countries in the last 7 years. I have also participated in radio shows, and been interviwed in media in Spain, China and India. 

Lluis Pareras - Director at HealthEquity SCR 
Lluis has a PhD in Medicine and a Global Executive MBA (IESE). He has been director of Meditecnologia, and he leads the innovation and incubation program at COMB, investing in companies in the healthcare market. He was one of the founders of Medicina Television, a company where he has been general manager and board member for more than 4 years. Lluis is an author of numerous books in the field of innovation, technology, venture capital and healthcare. The last one being “Innovation and entrepreneurship in healthcare”, published both in Spanish and in English internationally (US and Europe). He writes several columns about healthcare venture capital in economic journals. In the academic space, he is associate professor of several business schools where he teaches regularly about healthcare innovation and venture capital (IESE, ESADE, EADA, UPC ,...). 

Josep Lluis Santfeliu, Ysios
Xavier Pont, Co-foShip2B
Ignacio Fonts, Inveready
Josep Mora, Idodi
Sara Ylipoti, Connector


Currently all major Spanish Business Angel Networks have confirmed attendance and we are partnering with IESE and ESADE, two of the world’s top business schools, among other major local stakeholders, to deliver a high-end event. 

About Innovation Forum 

Innovation Forum is a global, interdisciplinary network of over 10,000
researchers, industry leaders and entrepreneurs. It aims to connect
academia, industry and policy makers to accelerate technology development.

Further information can be found at;

Do you have questions about Invest In Innovation - High Yield or Hazard? ? Contact Innovation Forum Barcelona

Save This Event

Event Saved

When & Where

Mobile World Centre (MWC)
Carrer de Fontanella, 2
08002 Barcelona

Tuesday, 9 May 2017 from 17:00 to 21:00 (CEST)

  Add to my calendar
Invest In Innovation - High Yield or Hazard?
Things to do in Barcelona Seminar Science & Tech

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.